TABLE 1

Baseline characteristic of subjects by type 1 diabetes status and sex

WomenMen
Type 1 diabetesControlPType 1 diabetesControlP
n21221920
Age (years)44 ± 944 ± 80.7547 ± 1047 ± 60.89
Type 1 diabetes duration (years)22 ± 8NANA23 ± 8NANA
Glucose infusion rate (mg/kg FFM/min)6.2 ± 3.415.5 ± 4.8<0.00015.4 ± 3.710.0 ± 5.20.004
A1C (%)7.5 ± 0.95.4 ± 0.3<0.00017.5 ± 0.85.4 ± 0.3<0.0001
Fasting glucose (mg/dl)109 ± 1992 ± 60.0008124 ± 5399 ± 90.06
Final clamp glucose (mg/dl)89 ± 489 ± 30.9089 ± 291 ± 30.10
Baseline insulin (μU/ml)36 ± 358 ± 20.00127 ± 1610 ± 50.0002
Final clamp insulin (μU/ml)108 ± 40108 ± 330.96104 ± 3187 ± 230.06
Body fat (%)32.4 ± 6.734.7 ± 6.60.2724.3 ± 6.124.2 ± 3.20.92
BMI (kg/m2)25.8 ± 4.325.8 ± 4.30.9928.3 ± 4.327.2 ± 3.60.41
Visceral fat (cm2)10.5 ± 0.610.5 ± 0.30.9310.9 ± 0.411.0 ± 0.50.31
Physical activity (log kcal)7.2 ± 1.37.4 ± 1.10.527.3 ± 1.07.5 ± 0.80.50
Total cholesterol (mg/dl)135 ± 33171 ± 330.0009145 ± 32171 ± 250.007
HDL cholesterol (mg/dl)56 ± 1357 ± 100.7461 ± 3045 ± 90.03
Triglycerides (mg/dl)69 ± 4299 ± 400.0270 ± 22126 ± 730.003
LDL cholesterol (mg/dl)66 ± 2595 ± 290.000970 ± 25101 ± 250.0004
Taking statins (%)5290.00268150.001
Oral contraceptive pill use (%)86730.46NANANA
Postmenopausal (%)19320.49NANANA
  • Data are means ± SD or %. NA, not applicable.